Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Operating Expenses | 2,436 | 1,250 | 535 | 571 | 507 |
| Operating Income | -2,436 | -1,250 | -535 | -571 | -507 |
| Interest Expense | 268 | 108 | 19 | 18 | 22 |
| Other Income | -2,207 | -1 | 2 | 1 | -6 |
| Pre-tax Income | -4,910 | -1,358 | -552 | -588 | -536 |
| Net Income Continuous | -4,910 | -1,358 | -552 | -588 | -536 |
| Net Income | $-4,910 | $-1,358 | $-552 | $-588 | $-536 |
| EPS Basic Total Ops | -0.22 | -0.06 | -0.02 | -0.03 | -0.02 |
| EPS Diluted Total Ops | -0.22 | -0.06 | -0.02 | -0.03 | -0.02 |
| EBITDA(a) | $-4,619 | $-1,228 | $-510 | $-548 | $-498 |